Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles V Pollack

Showing results (121-130 of 232) with videos related to

Pageof 24
Sort By:
Annals of Emergency Medicine|December 6, 2006
The role of cardiac risk factor burden in diagnosing acute coronary syndromes in the emergency department settingJin H Han, Christopher J Lindsell, Alan B Storrow, et al.
Diabetes Care|December 24, 2005
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromesGerard X Brogan, Eric D Peterson, Jyotsna Mulgund, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 5, 2003
Can electrocardiographic criteria predict adverse cardiac events and positive cardiac markers?Andra L Blomkalns, Christopher J Lindsell, Abhinav Chandra, et al.
The New England Journal of Medicine|March 19, 2019
Antibody-Based Ticagrelor Reversal Agent in Healthy VolunteersDeepak L Bhatt, Charles V Pollack, Jeffrey I Weitz, et al.
BMJ Open|June 5, 2012
Self-reported cocaine use, emergency physician testing and outcomes in suspected acute coronary syndromes: a nested matched case-control studyYang Wang, Christopher J Lindsell, Charles V Pollack, et al.
American Heart Journal|May 3, 2005
Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromesDavid E Kandzari, Matthew T Roe, Anita Y Chen, et al.
Clinical Cardiology|February 4, 2010
Influence of clinical trial participation on subsequent antithrombin useBimal R Shah, Eric D Peterson, Anita Y Chen, et al.
Circulation|December 28, 2018
Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal BleedingSake J Van der Wall, Renato D Lopes, James Aisenberg, et al.
American Heart Journal|December 15, 2010
Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registryChiara Melloni, Bimal R Shah, Fang-Shu Ou, et al.
JAMA|August 18, 2005
Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarctionDavid J Magid, Yongfei Wang, Jeph Herrin, et al.
Pageof 24

Showing results (121-130 of 232) with videos related to

Sort By:
Pageof 24
Annals of Emergency Medicine|December 6, 2006
The role of cardiac risk factor burden in diagnosing acute coronary syndromes in the emergency department settingJin H Han, Christopher J Lindsell, Alan B Storrow, et al.
Diabetes Care|December 24, 2005
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromesGerard X Brogan, Eric D Peterson, Jyotsna Mulgund, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 5, 2003
Can electrocardiographic criteria predict adverse cardiac events and positive cardiac markers?Andra L Blomkalns, Christopher J Lindsell, Abhinav Chandra, et al.
The New England Journal of Medicine|March 19, 2019
Antibody-Based Ticagrelor Reversal Agent in Healthy VolunteersDeepak L Bhatt, Charles V Pollack, Jeffrey I Weitz, et al.
BMJ Open|June 5, 2012
Self-reported cocaine use, emergency physician testing and outcomes in suspected acute coronary syndromes: a nested matched case-control studyYang Wang, Christopher J Lindsell, Charles V Pollack, et al.
American Heart Journal|May 3, 2005
Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromesDavid E Kandzari, Matthew T Roe, Anita Y Chen, et al.
Clinical Cardiology|February 4, 2010
Influence of clinical trial participation on subsequent antithrombin useBimal R Shah, Eric D Peterson, Anita Y Chen, et al.
Circulation|December 28, 2018
Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal BleedingSake J Van der Wall, Renato D Lopes, James Aisenberg, et al.
American Heart Journal|December 15, 2010
Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registryChiara Melloni, Bimal R Shah, Fang-Shu Ou, et al.
JAMA|August 18, 2005
Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarctionDavid J Magid, Yongfei Wang, Jeph Herrin, et al.
Pageof 24